Phase 4 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 80 years old (any gender)
- You have been diagnosed with pancreatic cancer confirmed by a tissue sample (biopsy or surgery), and you had surgery to remove the cancer within the last 12 weeks before joining the trial
- You did not receive any treatment before or after your surgery (such as chemotherapy or radiation) prior to enrolling
- Your general health and ability to carry out daily activities falls within an acceptable range as judged by a doctor (confirm with trial site)
- You have chosen on your own either to receive standard chemotherapy or to take a herbal product called Huaier granules as your next treatment, and you are willing to take part in all parts of the study, including follow-up appointments and data collection, without seeking other treatments at the same time
- You are willing and able to sign a written consent form before joining the study
Who may not be able to join:
- You have a known allergy to Huaier granules or have been advised to avoid them (applies to those choosing Huaier granules)
- You have an active condition such as gastrointestinal bleeding, a hole in your stomach or bowel, or a stomach that does not empty properly, making it hard to take medication by mouth
- You have a serious mental health condition or another reason the research team feels makes participation unsuitable
- You have a history of any other type of cancer
- You have had a heart attack, stroke, or a serious blood clot condition that required surgery
- You currently have a severe infection
- You have significantly reduced liver or kidney function (confirm with trial site)
- You are pregnant, breastfeeding, or planning to become pregnant
- You have received certain anti-cancer herbal medicines, chemotherapy, or radiation therapy in the past 4 weeks before joining (confirm with trial site for the full list of medicines this includes)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zheng Wang, PhD, First Affiliated Hospital Xi'an Jiaotong University
Phone: +8615902993665
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.